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Abstract
The rate at which a cytotoxic T lymphocyte (CTL) can survey for infected cells is a key ingredient of models of vertebrate
immune responses to intracellular pathogens. Estimates have been obtained using in vivo cytotoxicity assays in which
peptide-pulsed splenocytes are killed by CTL in the spleens of immunised mice. However the spleen is a heterogeneous
environment and splenocytes comprise multiple cell types. Are some cell types intrinsically more susceptible to lysis than
others? Quantitatively, what impacts are made by the spatial distribution of targets and effectors, and the level of peptide-
MHC on the target cell surface? To address these questions we revisited the splenocyte killing assay, using CTL specific for
an epitope of influenza virus. We found that at the cell population level T cell targets were killed more rapidly than B cells.
Using modeling, quantitative imaging and in vitro killing assays we conclude that this difference in vivo likely reflects
different migratory patterns of targets within the spleen and a heterogeneous distribution of CTL, with no detectable
difference in the intrinsic susceptibilities of the two populations to lysis. Modeling of the stages involved in the detection
and killing of peptide-pulsed targets in vitro revealed that peptide dose influenced the ability of CTL to form conjugates
with targets but had no detectable effect on the probability that conjugation resulted in lysis, and that T cell targets took
longer to lyse than B cells. We also infer that incomplete killing in vivo of cells pulsed with low doses of peptide may be due
to a combination of heterogeneity in peptide uptake and the dissociation, but not internalisation, of peptide-MHC
complexes. Our analyses demonstrate how population-averaged parameters in models of immune responses can be
dissected to account for both spatial and cellular heterogeneity.
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Introduction
Cytotoxic T lymphocytes (CTL) prevent the spread of
intracellular pathogens through T cell receptor (TCR) recognition
of pathogen-derived peptides presented on MHC class I molecules
on the surface of infected cells. CTL may have several modes of
action but their canonically understood role is to kill cells
recognised as infected, either through delivery of lytic mediators
through the target cell membrane or engaging ligands on the cell
surface that induce apoptosis.
Quantifying the kinetics of CTL killing has been of interest for
many years [1–19] (see ref. [20] for a review) and is important for
at least two reasons. First, knowledge of the rate at which
individual CTL can survey and kill cells allows us to derive
estimates of the numbers or tissue densities of CTL required to
contain an infection. Second, developing tools to measure the
kinetics of the different processes involved in lytic activity (locating
cells, forming stable conjugates, lysing the infected cell and
dissociating from it) may help us to understand how ineffective or
exhausted CTL are functionally impaired or to identify bottlenecks
in the lytic process that may be potential targets for augmenting
CTL responses.
Early studies of CTL-target dynamics were performed almost
exclusively in vitro but more recently there has been some focus on
data from splenic killing assays, using variants and generalizations
of the experimental and modeling approach taken by Barchet et
al. [21] and Regoes et al. [11]. There, mice are challenged with a
pathogen and following the clearance of infection, a mixture of
isogenic splenocytes either pulsed with pathogen-derived peptides
or left as unpulsed controls is injected intravenously. Proportions
of both populations accumulate in the spleen, where the peptide-
pulsed cells can be killed by resident epitope-specific CTL. Models
of the kinetics of the transferred cell populations in the spleens in
the hours following transfer have yielded estimates of the rate at
which single spleen-resident CTL are able to survey and kill.
These models assume that CTL and targets are interacting in a
well-mixed environment and have provided reasonable descrip-
tions of the data with the assumption that peptide-pulsed targets
are lost with first-order kinetics. When CTL are present in excess –
that is, at high effector:target (E:T) ratios – one can assume that
the total rate at which targets are killed is not limited by the time
each CTL takes to lyse its target [22]. The simplest model of CTL
activity then assumes that the per-capita rate of loss of targets is
kC, where C is a measure of CTL density or numbers in the
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spleen. The units and magnitude of C dictate the interpretation of
the constant k, but if C is measured as a proportion of all
surveyable cells in the spleen, k is the rate at which one CTL can
move between cells of any type, multiplied by the probability of
lysis upon engagement with a peptide-pulsed or infected cell (Text
S1, section A). We term k the ‘effective surveillance rate’. If killing
is assumed to occur with 100% efficiency, k is simply the rate of
CTL surveillance, and has been estimated to be in the range 1–35
cells per minute in a variety of experimental infection systems
[11,12,16,18]. In simple models of well-mixed CTL and targets,
knowledge of this parameter, the time taken for CTL to lyse
infected cells, and the uncontrolled pathogen growth rate are
sufficient to calculate the critical CTL density required to control
an infection [22].
These studies took a rather coarse-grained view of CTL-target
dynamics that may mask several potential sources of heterogeneity
and CTL biology. First, the assays are performed with mixed
splenocyte populations but these models assumed all cells are
detected and killed with equal efficiencies. Are some cell
populations intrinsically easier to kill than others? Second,
although CTL have been shown to be able to respond in a
dose-dependent manner to very low levels of peptide-MHC
(pMHC) ligands on a cell surface [23,24], it is not clear whether
this susceptibility varies across cell types, or at what stage in the
killing process any effect of pMHC availability is manifest. Third,
the models assume the spleen to be a single compartment, but it is
a heterogeneous environment with areas enriched for T cells, B
cells and red blood cells, raising the possibility that cell populations
are not well-mixed and cells of different types may be exposed to
different CTL densities. To explore these issues we used a
combination of in vivo and in vitro killing assays to examine the
influence of target cell heterogeneity, peptide dose and spatial
heterogeneity on the kinetics of CTL activity in vivo.
Results
Basic model of splenic killing kinetics
We revisited the splenic killing assay in the setting of influenza
infection (Figure 1). The experimental system is detailed in
Materials and Methods, but briefly, TCR transgenic F5 T cells
specific for the NP68 influenza epitope were transferred to
congenic mice and challenged with systemic administration of live
influenza virus. Our calculations depended on being able to
enumerate the CTL capable of participating in lysis of pulsed
targets. Tetramer staining one week after challenge revealed that
transferred F5 cells outnumbered endogenous CTL specific for the
NP68 influenza epitope roughly 500-fold in the spleen (Text S1,
section B). We therefore assumed that F5 numbers were a
reasonable approximation to the number of antigen-specific
effector cells in the spleen. To assess the cytotoxic activity of
these CTL, total splenocytes from donors were pulsed with four
different doses of peptide, with each dose associated with a
different level of cell dye, then transferred intravenously to
influenza-immunised hosts. T and B cell targets were identified
by the expression of either TCR or B220, yielding 8 different
target cell populations.
The original model of the kinetics of transferred cells in blood
and spleen [11] assumed pulsed and unpulsed cells flow from
blood to spleen in the same ratio as they are present in the
inoculum, and that transferred, unpulsed cells are not lost from the
spleen after entry over the course of the assay. We found direct
evidence challenging both of these assumptions (Text S1, section
C), so as a starting point we extended the model to allow for (1) a
rate of enrichment E of unpulsed cells relative to pulsed cells in the
blood over time, and (2) a rate of loss w of the transferred cell
populations from the spleen through egress and/or death due to
non-CTL-related mechanisms. The basic model is then repre-
sented with the following:
dUblood
dt
~{(szd)Ublood ð1Þ
dPblood
dt
~{(szdzE)Pblood ð2Þ
dUspleen
dt
~sNUblood{wUspleen
~sNUblood(0)e
{(szd)t{wUspleen
ð3Þ
dPspleen
dt
~sNfPblood{(K0zw)Pspleen
~sNPblood(0)e
{(szdze)t{(K0zw)Pspleen,
ð4Þ
where in equations 3 and 4 we have inserted the solutions for the
time-dependent densities of transferred cells in blood (equations 1
and 2). All populations are assumed to enter the spleen from the
blood at per-capita rate s. Unpulsed and pulsed cells die in the
blood or migrate into locations other than the spleen at rates d and
dzE, respectively. K0 is the per-capita rate of loss of pulsed targets
in the spleen due to lysis by CTL, and Pblood(0) and Ublood(0) are
the initial concentrations of pulsed and unpulsed cells in the blood,
respectively.
The quantity of interest is the ‘fractional killing’ in the spleen or
the extent of loss of pulsed relative to unpulsed cells,
(1{Pspleen=fUspleen) for each transferred cell population, in which
the quantity f corrects for departures from a 1:1 ratio of pulsed to
unpulsed cells in the inoculum (see Materials and Methods). The
fractional killing therefore lies in the range [0,1]. Using this
quantity controls to some extent for variation across animals in the
Author Summary
Measurements of the rates at which a single cytotoxic T
lymphocyte (CTL) can survey for infected cells, and kill
them upon encounter, are important for constructing
predictive models of vertebrate immune responses to
intracellular pathogens. The surveillance rate has been
estimated previously using combinations of modeling and
experiment, making the assumption that CTL and target
cells are well-mixed and that all cell types are killed with
equal efficiency. In this study we take an iterative approach
with theory and experiment to go beyond such models
and detail the effects of cellular heterogeneity, the spatial
organisation of the tissue within which killing is taking
place, and the influence of the level of expression of
peptides on the target cell surface. We demonstrate that
determining the degree of co-localisation of effector and
target cells, and the level of peptide expression on targets,
are most important for improving estimates of CTL killing
rates. Further, while the probabilities of killing upon
conjugation of CTL with T and B cell targets are similar, T
cells take substantially longer to kill than B cells, an effect
that may be important when CTL numbers are limiting.
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number of cells recovered from the spleen. Because it is
dimensionless, units of measurement of cell numbers in blood
and spleen do not need to be specified in this calculation. The
constant N in equations 3 and 4 relates the units of cell numbers in
the blood to those in the spleen, and appears linearly in the
solutions to equations 1 – 4. In combination with the spleen influx
rate s it therefore disappears from the ratio Pspleen=Uspleen (Text
S1, section D).
Before using equations 3 and 4 to estimate the killing rate K0
from the fractional killing, the total rate that unpulsed cells leave
the blood (szd) and the splenic loss/egress rate (w) were estimated
by fitting equation 3 to the timecourse of unpulsed cells in the
spleen (Text S1, section C). We chose to measure cell population
sizes as proportions of total splenocytes. This measure exhibited a
much smaller coefficient of variation than total numbers in the
spleen (Data S1), possibly due to variation in spleen size across
animals and associated differences in the total rate of ingress of
lymphocytes. The excess rate of loss of pulsed over unpulsed
targets from the blood, E, was estimated independently from
observations of the ratio of pulsed to unpulsed transferred cells in
the blood up to 18 hours post-transfer (Text S1, section C). Using
these estimates (shown in Table 1) left only the target cell death
rate due to CTL, K0, to be estimated from the timecourse of the
fractional killing, 1{Pspleen=f Uspleen. The further assumption of
mass-action at the whole spleen level corresponds to K0~kC
where k is the effective surveillance rate and C is the measured
number of F5 CTL in the spleen as a proportion of total
splenocytes.
Equations 1-4 predict that the fractional killing should asymp-
totically approach 1, simply because the per-capita rates of loss of all
populations are constant over time and the loss rate is higher for
pulsed than unpulsed cells. However the loss of pulsed targets
stopped short of 100%, an effect more pronounced for T than B
cells and increasingly apparent at lower peptide doses. To account
for this saturation, we explored three extensions of the basic model,
illustrated in Figure 2 and detailed in Text S1, section D.
1. The decay model. Here we assumed that the CTL-
mediated death rate of pulsed targets in the spleen falls
exponentially with time [12,18]. Such a decay might reflect the
exhaustion of effector CTL required to kill multiple times,
although in our assays the ratio of CTL to pulsed targets was 3
or greater (Text S1, section E) and so this mechanism seems
unlikely. Another interpretation of the decay over time is that
peptide-pulsed cells became progressively less visible to CTL due
to loss of peptide from, or natural turnover of, MHC on the cell
surface. This will reduce the effective surveillance rate. In this
model the CTL-mediated death rate decays as K0 exp ({mt).
2. The hidden-target model. Here we assumed that only a
proportion q of the population is susceptible to killing. The
remaining fraction 1{q might represent a proportion of pulsed
targets being physically inaccessible to CTL or refractory to killing
over the entire course of the assay.
3. The hybrid model. Here pulsed targets transition at some
rate n into a non-susceptible population, a model similar to that
proposed in ref. [13] and reflecting elements of both the decay and
hidden-target models. This model might represent a loss of peptide
from target cells, which renders them invisible to CTL below some
threshold level of surface expression of pMHC.
Modeling blood-spleen recirculation
We combine egress and non-specific cell death in the spleen in a
single loss rate (w). Similarly the rate d combines both death in the
blood and the net rate of extra-splenic sequestration of unpulsed
targets. An integrated model of spleen-blood kinetics would allow
for a proportion of targets lost from the spleen to re-enter the
circulation, a process that would contribute to the enrichment for
unpulsed cells in the blood over time. Instead we represent the
population dynamics of cells in the blood semi-empirically with
equations 1 and 2, which recapitulate the kinetics of the
pulsed:unpulsed ratio in blood and of unpulsed cells in the spleen
(net influx slowing to zero by 6h, followed by a net loss). Killing
also slows to near zero by 6h (Figure 3A) and our estimates of
parameters related to CTL activity are insensitive to the splenic
loss rate w, suggesting it is reasonable to use our description of
blood kinetics. This assumption also eliminates the need to
estimate the potentially different non-specific death rates in blood
and spleen.
CTL killing rates vary with target cell type and peptide
dose
We fitted these three models to the data, estimating the CTL-
mediated killing rate K0 and the additional parameter for each
model (m, q or n) separately for the two target cell populations. To
complete the analysis we found that the addition of a third
Figure 1. The in vivo killing assay.
doi:10.1371/journal.pcbi.1003805.g001
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parameter, a time lag T , was required to account for the fact that
the fractional killing curves did not extrapolate cleanly to zero at
the beginning of the assay (Figure 3A). T represents a delay
between transfer and the first evidence of death of pulsed cells. It
might comprise the mean time taken to migrate from blood into
the spleen and across the marginal zone into white pulp where we
would expect specific CTL to be resident in the greatest numbers.
It may also comprise the handling time, the time taken for a target
to be killed following conjugation with a CTL. Because splenic
effector:target ratios were high in these assays (Text S1, section E),
few CTL are expected to kill more than once and so the handling
time is not expected to limit the total rate of killing, but it may act
to delay the appearance of the first apoptotic cells. If the times to
complete any or all of these process are non-exponentially
distributed, or if more than one process is operating, there may
be a discernable delay before killing is observed. We model the
effect of migration and/or handling time by setting the killing rate
K~0 for times tƒT and Kw0 for twT , where K is time-
dependent for the decay model, K(t)~K0 exp ({mt), and a
constant K0 for the hidden-target and hybrid models. We found
that our estimates of the time lag T did not vary significantly
across peptide doses and so assumed that it took values specific to
the T or B cell populations only.
Due to the non-nested nature of the models we compared their
abilities to describe the data using the Akaike Information Criterion
(AIC) [25]. Since the three models contained equal numbers of
parameters, the AIC could be calculated simply as n log(RSS) where
RSS is the residual sum-of-squares and n is the number of
datapoints. This quantity is the negative of twice the (maximum)
log-likelihood up to an additive constant in nwhich disappears when
comparing models. We found strongest support for the hybrid
model and the weakest for the decay model, for both T cell and B
cell targets (Hidden-target vs. hybrid model, DAIC~5:6 for T
cells, 3:0 for B cells; Decay vs hybrid model, DAIC~21:6 for T
cells, 17 for B cells). The interpretation of these differences is that the
relative probability of the hidden-target and not the hybrid model
minimising the information lost in describing the data is
exp ({5:6=2)~0:06 for T cells and exp ({3=2)~0:22 for B cells.
However the fits were visually indistinguishable on both the absolute
scale and the logit-transformed scale on which fitting was
performed, and parameter estimates were comparable. Graphs of
fits and parameter estimates for the Hybrid model are shown in
Figure 3 and parameter estimates for all three models are shown in
Table 1. Reduced models with no pre-killing lag time T yielded
substantially inferior fits (for the hybrid model, DAIC~65, 71 for
B and T cells respectively).
Our key observations are that every model indicated that within
the susceptible populations B cells were killed significantly more
slowly per-capita than T cells at all doses except the lowest, and for
both populations the rate of killing of susceptible targets K0 fell
with peptide dose (Figure 3B and Table 1). While we will argue
that spleen-averaged estimates may be misleading, to allow
comparison with estimates of the effective surveillance rate k
from other studies and pathogens, we quote here the spleen-
averaged k~K0=C where C~0:029 was the average number of
F5 cells as a proportion of splenocytes across all animals and all
timepoints. The effective surveillance rates of F5 effectors for T
cell targets (with 95% CIs) ranged from 0.14 (0.12–0.16)/min at
the lowest peptide dose to 0.44 (0.40–0.50)/min at the highest
dose, and from 0.15 (0.13–0.17)/min to 0.27 (0.24–0.30)/min at
low/high doses for B cells. Interpreting these figures in terms of
numbers of targets surveyed per unit time is complicated by the
fact that k combines both the base cell-cell surveillance rate k and
the probability that a CTL kills a pulsed target on encounter, p,
Figure 2. Three alternative models of the kinetics of peptide-pulsed and unpulsed cells in the blood and spleen. In the Decay model,
peptide-pulsed targets uniformly and gradually lose susceptibility to lysis; in the Hidden-target model, only a proportion q of peptide-pulsed targets
are susceptible to lysis; and in the Hybrid model, peptide-pulsed targets maintain susceptibility but transition at per-capita rate n into a non-
susceptible state.
doi:10.1371/journal.pcbi.1003805.g002
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which may be v1; so the estimates of k at higher peptide doses
where one might expect killing efficiency to be greatest [26] are
likely closest to the base surveillance rate k but still a lower
bound. Mempel et al. [27] used intravital imaging to study the
lysis of peptide-pulsed B cell targets by specific CTL in a
popliteal lymph node, and estimated that CTL take 2:2+1:7
minutes in vivo to survey cells not expressing cognate antigen.
Our figures are consistent with this if one assumes that in their
system the time for a CTL to migrate between surveyable cells
was short.
Estimating k from the target cell death rate K0 also requires the
assumption that all target cell populations are exposed to the same
spleen-averaged density C. This assumption is questionable, as we
see below. Another caveat is that K0 is the rate of killing of
susceptible targets only; if any targets are refractory or inaccessible
to CTL, then models that assume all targets are susceptible such as
in [11] will underestimate K0. Estimates of k derived from these
models may then also be lower bounds. Nevertheless the effective
surveillance rates in the setting of influenza infection and F5
transgenic CTL are slower than those estimated using LCMV or
Figure 3. Modeling the in-vivo cytotoxicity assay. A: Timecourses of fractional killing in the spleen, broken down by peptide dose between
10{6 M and 10{9 M, decreasing top to bottom) and target cell type, with 5 mice per time point (green points). Curves show the predictions of the
best-fitting (hybrid) model. B: Key best-fit parameters governing killing of pulsed targets in the spleen, with 95% confidence intervals.
doi:10.1371/journal.pcbi.1003805.g003
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polyomavirus infections [11,12,16,18], an issue we return to in the
Discussion.
Splenic egress and differential loss of pulsed and
unpulsed targets from blood influence estimates of
effective surveillance rates only weakly
Modeling splenic egress and enrichment of unpulsed targets in
the blood was required to explain the kinetics of unpulsed targets
in the spleen and of the pulsed:unpulsed ratio in the blood,
respectively (Text S1, section C). Including these processes in the
models of killing improved their qualities of fit slightly (for the
hybrid model, neglecting splenic egress and blood enrichment
increased the AIC by 1.6 for B cells and 1.9 for T cells) but had no
substantial impact on parameter estimates or the relative support
for the three models. This is likely due in part to a disparity in
timescales. Our estimates of the time for the pulsed:unpulsed ratio
to halve in the blood were 4.3 h for T cells and 11.4 h for B cells
(log (2)=E, Table 1). In contrast, the total rate of influx of unpulsed
cells into the spleen is proportional to s exp ({(szd)t) in these
models and was estimated to halve in 1.3 h for T cells and 1.5 h
for B cells (log (2)=(szd), Table 1). Thus, the differential influx of
the pulsed and unpulsed cells into the spleen became apparent
only after the majority of targets had accumulated. Further, we
assumed that the splenic egress or non-specific loss rate w applied
to pulsed and unpulsed populations equally, and so including this
process only weakly influences the timecourse of the pulsed:un-
pulsed ratio in the spleen. We note that other estimates of times to
transit the spleen are lower, and that T cells may egress more
rapidly than B cells [28,29], suggesting that killing in the spleen
may indeed contribute to the enrichment for unpulsed cells in the
blood.
The delay before killing, T , was comparable for T and B cells at
approximately 75 minutes. T and B cells take 20–30 minutes
following intravenous transfer to cross the marginal zone of the
spleen and enter the white pulp [30]. A handling time between
encounter and breakup of the target cell has been observed in
many studies. A study of killing of B cells in vivo found CTL took
between 9–25 minutes to lyse targets after conjugation [27]. Note
that the models predicted an increase in the fractional killing in the
spleen during the lag period 0vtvT , most strongly for T cells
(Figure 3A and Table 1). However by neglecting recirculation we
predict this is due to the slow but significant enrichent for unpulsed
over pulsed T cell targets from the blood into other anatomical
locations, and not killing in the spleen itself.
No detectable signature of mass-action killing kinetics at
the whole-spleen level
To investigate whether we could detect evidence of mass-action
killing operating, following ref. [12] we allowed for the base killing
rate K0 to be specific to each mouse, K
(i)
0 , and assumed it was
linearly proportional to the density of effector CTL in the spleen of
that animal, K
(i)
0 ~kC
(i). Here C(i) is the measured number of F5
CTL as a proportion of all splenocytes, and k is the effective
surveillance rate. We assumed that k was constant across animals
but took values specific to each target cell type (T or B cell) and
peptide dose.
Effector:target ratios were greater than 3 in these assays (Text
S1, section E), so if CTL and targets were well-mixed in the spleen
and moving randomly, mass-action might be expected to hold.
However, we found that across all peptide doses and target cell
types the models using a simple population-average killing rate K0
described the data significantly better than those with mouse-
specific, mass-action killing rates K
(i)
0 ~kC
(i). Indeed we saw no
significant positive correlation between fractional killing and F5
CTL, either in total numbers or as a fraction of splenocytes, at any
peptide dose or timepoint, after correcting for multiple compar-
isons (Text S1, section F). We saw roughly 40% variability across
animals in the total number of F5 CTL recovered from the
spleens, C~(6:4+2:5)|106. However the dependence of the
rate of loss of targets on the size of the CTL population might be
expected to be an increasing function of their density, rather than
of total numbers alone; the rate of encounter of targets with a
given number of randomly dispersed CTL would be expected to
vary with spleen volume if the populations are well-mixed. F5
CTL numbers as a proportion of all splenocytes were highly
consistent across animals and timepoints (C~0:029+0:004, or
14% variation). We conclude that our data do not provide
sufficient power to support or refute the mass-action hypothesis at
the whole-spleen level, nor do they allow us to quantify any
functional dependence of killing rates on CTL densities. Ganusov
et al. [19] performed these assays in the context of LCMV
infection, using adoptive transfer of specific CTL and varying their
number over three orders of magnitude, and did indeed find
evidence for a linear dependence of splenocyte death rates on
CTL numbers or frequencies, and so in the analyses below we
retain the possibility that mass-action operates.
Arrest in killing likely arises from a combination of
progressive loss of peptide from the cell surface and
heterogeneous uptake of peptide, but not spatial effects
or MHC turnover
Another key observation derived from the hybrid model is that
the average rate at which pulsed target cells lost susceptibility
increased by an order of magnitude as peptide dose fell from
1026 M to 1029 M, most rapidly for T cells. This effect was
reflected in the hidden-target model by the susceptible fraction
declining with dose, and generally being smaller for T cells than B
cells (Figure 3B and Table 1). These dose-dependencies suggest
that heterogeneity in susceptibility derives from properties intrinsic
to target cells rather than global effects such as cells migrating into
regions in the spleen inaccessible to CTL.
In the light of these observations, the following is a mechanism
of loss of susceptibility compatible with the hybrid model:
N Peptide is progressively shed from targets or internalised;
N CTL are able to recognise targets with a probability that is an
increasing function of peptide dose, likely sigmoid;
N Targets become effectively invisible below a threshold level of
surface expression of cognate pMHC.
Peptide-pulsed targets would be expected to exhibit a unimodal
distribution of pMHC densities at each dose, and if peptide is lost
this distribution will shift towards lower pMHC densities with
time. The lower the dose of peptide, the closer to any threshold of
detection the initial distribution will be, and so the average rate of
loss of susceptibility across the entire target population (the rate n
in the hybrid model) will increase, as observed.
To explore the peptide-loss hypothesis, we quantified the
expression and turnover of MHC class I on T and B cells in vitro
by blocking transport of MHC class I to the cell surface and
observing the kinetics of its internalisation (see Materials and
Methods). We found T cells expressed MHC class I on the cell
surface at 2–3 fold lower levels than B cells, and MHC was lost
approximately twice as rapidly (Figure 4; half-lives of approxi-
mately 11 and 21 h for T and B cells respectively). If these peptide-
MHC turnover rates in vitro reflect the rate of turnover in vivo,
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then in our splenic cytotoxicity assays pMHC densities on the T
cell targets fall only approximately 2-fold before the bulk of
surviving pulsed cells are below a threshold of detection and killing
has stopped. This means that for loss of MHC to underlie arrest in
the hybrid model, peptide doses covering four orders of magnitude
result in four target cell populations clustered closely in pMHC
expression just above the limit of detection. Parsimony then
suggests that it is unlikely that MHC internalisation alone explains
the arrest of killing, as suggested previously [13].
MHC turnover imposes only a lower limit on the rate of loss of
visibility of targets, as peptide may dissociate from the MHC class I
to which it is bound. While we do not have an estimate of the
lifetime of the NP68/H-2Db complex used in our assays, peptide-
MHC class I dissociation half-lives of 1–4 h have been reported in
other systems [31–33] and so loss of peptide from targets remains a
potential explanation for loss of susceptibility. However we cannot
exclude a contribution from heterogeneity in peptide uptake by
targets such that at decreasing peptide doses, an increasing
proportion of pulsed targets are already below a threshold of
detectability by CTL at the beginning of the assay. The hidden-
target model, which describes the data with fidelity comparable to
the hybrid model, at least visually if not statistically, is an
expression of this heterogeneity in initial conditions.
Finally, the dependence of the B cell killing rate on peptide dose
was weaker than that of T cells (Figure 3B and Table 1). One
explanation for this is that the higher level of MHC expression on
B cells means at higher peptide doses the population lies more
completely within a saturating region of the curve relating dose to
susceptibility to CTL.
Differences in rates of killing of T and B cell targets
cannot be explained purely by differences in CTL
densities in T and B cell areas using a mass-action model
All three models indicated that the per-capita rate of killing by
CTL was lower for B cell targets than for T cells. This may be
because B cells are intrinsically less susceptible to lysis at a given
peptide dose, that B and T cells encountered different local
densities of CTL, or that the CTL were less motile in B cell
areas than in T cell areas. To begin to discriminate between
these (non-exclusive) possibilities, we used microscopy to
quantify the distribution of effector CTL within the spleen
(Figure 5A). F5 CTL were indeed distributed heterogeneously,
with the majority (60%) in T cell areas, roughly 4-fold fewer
(13%) in B cell follicles, and more than a quarter (27%) in red
pulp (Figure 5B).
Since at least a proportion of the intravenously injected T and B
cell targets may migrate to their respective areas in the spleen, it
then seems likely that the different target cell populations are
exposed to different local densities of CTL. To further explore the
relative contributions of this spatial heterogeneity and potential
differences in susceptibility to lysis, we used this spatial data
together with the T and B cell death rates to estimate the relative
ability of F5 CTL to kill peptide-pulsed B and T cells. To separate
the effects of CTL numbers and susceptibility we began by
assuming that mass-action held within the T and B cell areas and
killing of each population was restricted to its relevant area.
Targets and CTL might reasonably be assumed to be randomly
distributed within each.
In the hybrid and hidden-target models the per-capita rate of
killing of the susceptible population of peptide-pulsed T cells in the
spleen is K0,T . If these T cells are restricted to T cell areas and are
exposed to specific CTL at local density CT , this killing rate must be
equal to kTCT where kT is the effective surveillance rate in T cell
areas. So K0,T~kTCT , and similarly for B cells. Note that this
calculation does not depend on the relative volumes of B and T cell
regions in the spleen, which we estimated to be 1:71+0:18 (mean
+ s.e.m.) by raising the ratio of their areas in the imaged sections to
the power 3=2. Different degrees of crowding of T and B cell targets
in the spleen are represented by different values of the parameterN,
which relates density units in blood and spleen but disappears from
the estimation of K0 for each population. Then
kB
kT
~
pBkB
pTkT
~
K0,B
K0,T
|
CT
CB
^
K0,B
K0,T
|
~CT
~CB
: ð5Þ
Here kB and kT are decomposed into the probabilities of lysis
following encounter with a CTL, pB and pT , and the base CTL
surveillance rates in B and T cell areas, kB and kT .
In this calculation we have replaced the local densities of CTL in
each of the T and B cell areas (as fractions of total splenocytes within
each region) with ~CT and ~CB, the measured local CTL densities in
units of cells per mm2 of spleen section. Because these sections were of
the order one cell width deep, the CTL densities measured per unit
volume are then approximately these cell numbers per unit area
divided by the section depth. We assume the densities of total
surveyable cells are the same in T and B cell areas, and so
CT=CB^~CT=~CB. Using the target cell death rates derived from the
hybrid model, we estimate that on a per-CTL basis B cells are killed 3-5
times more rapidly than T cell targets, with the lower boundary of the
95% confidence interval lying above 1, at all peptide doses (Figure 5C,
solid circles). The hidden target model yielded very similar estimates
(Figure 5C, open circles).
In summary, under the assumptions of mass-action and restriction of
the populations to their respective areas in the spleen, the difference in
local densities of CTL was too large to explain the difference in killing
rates of T and B cells pulsed with the same dose of peptide, and so the
relative paucity of CTL in B cell areas is compensated to a degree by a
higher effective surveillance rate (kBwkT ).
Analysis of CTL-target dynamics in vitro
This difference in k might stem from susceptibility to lysis; for
instance, the 2–3 fold difference in MHC expression by B cells
might contribute to a higher probability of detection by CTL upon
encounter, p, at a given peptide dose. It might also arise from
Figure 4. Kinetics of MHC class I turnover on B and T cells. MHC
class I expression was measured (MFI, arbitrary units) following blocking
of its transport to the cell surface. Its decay followed approximately
first-order kinetics, and occurred faster on T than on B cells.
doi:10.1371/journal.pcbi.1003805.g004
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differences in the motility of CTL within T and B cell areas, kT
and kB. To narrow down the possibilities even further, we wanted
to estimate the intrinsic susceptibilities of T and B cells to lysis by
CTL and assess their dependence on peptide dose, while
minimising any effects of spatial heterogeneity or CTL motility.
Lysis is a multi-stage process. The CTL must encounter and
survey the cell, detect that it bears the relevant peptide, form a
stable conjugate, initiate lysis and eventually disengage from the
apoptotic cell. We wanted to identify at which stage(s) of the killing
process any differences between T and B cells or across peptide
doses were manifest most strongly. To do this we performed an in
vitro cytotoxicity assay using T and B cell targets pulsed as before
with different doses of the peptide, and co-localised with F5 CTL
activated in vitro (see Materials and Methods). These populations
were co-cultured for between 0 and 120 minutes, allowing us to
follow the kinetics of free targets (S), the number of CTL-target
conjugates in which the CTL had not degranulated (stained
negative for LAMP1a at the cell surface, L{), and the number of
conjugates in which the CTL had degranulated (LAMP1a
detected at the cell surface, Lz), assumed to indicate lysis.
The following generalisation of the hybrid or decay models
described the kinetics of these populations well (Figure 6):
dS
dt
~{xe{mtSzwemtL{ ð6Þ
dL{
dt
~xe{mtS{wemtL{{se{mtL{ ð7Þ
dLz
dt
~se{mtL{{gLz: ð8Þ
The term proportional to x is the total rate of formation of
conjugates between targets and LAMP1a2 CTL. At the beginning
of the assay the expected time for a given target to become
conjugated is 1=x. w is the initial rate at which a conjugate
dissociates without lysis; s is the initial rate at which a CTL in a
conjugate becomes LAMP1a+ through degranulation; and g is the
rate at which a LAMP1a+ conjugate dissociates. CTL were in
excess in this assay and so we assumed LAMP1a+ cells did not kill
again. With this assumption, LAMP1a+ conjugates arose directly
from LAMP1a2 conjugates only.
Inspection of the data revealed that the formation of conjugates
and killing slowed considerably over the course of the assay,
appearing to stop completely after roughly an hour (Figure 7).
This was much earlier than the timescale of arrest of killing in vivo
(Figure 3A), and seems unlikely to be the result of loss of peptide-
MHC from the target cells. We observed a roughly 50% loss of
effector CTL numbers over the 2h timecourse, accounting for
Figure 5. Influenza-specific F5 CTL are distributed heterogeneously within the spleen. A: Imaging of the spatial distribution of F5 CTL
within T and B cell areas and red pulp of spleen. B: Statistical comparison of F5 densities in these areas. C: Using equation 5 with these data to
establish the relative efficiency with which F5 CTL kill B and T cell targets after locating them.
doi:10.1371/journal.pcbi.1003805.g005
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both free CTL and those in conjugates. We speculate that as well
as dying, the CTL became increasingly functionally impaired,
perhaps related to the release of cytotoxic factors into the culture
medium. To capture this behaviour we allowed rate constants to
change with time such intially they reflect the interactions between
targets and fully-functional CTL, but by t&1=m, conjugate
formation had stopped, and the efficiency of progression to
degranulation was zero;
P(degranulation): lytic efficiency p~
se{mt
se{mtzwemt
~
s
szwe2mt
:
ð9Þ
Parameter estimates are shown in Figure 8 and rate constants
are quoted as their inverses (timescales, in minutes). CTL and
targets formed conjugates at similar rates (x) for T and B cells at
each peptide dose, but conjugates were slower to form at lower
doses (Figure 8A). CTL-B cell conjugates progressed to degran-
ulation (LAMP1a+, which we assumed led to lysis) after roughly 15
minutes, independent of dose, while the mean time to degranu-
lation for CTL-T cell conjugates was roughly 30 minutes slowing
to 45 minutes at the lowest peptide dose (Figure 8B). We saw
considerable uncertainty in the rate of dissociation without lysis,
the failure rate w (Figure 8C), but this process was relatively slow
and the mean lifetime of LAMP1a2 conjugates (1=(wzs)) was
determined largely by the time to degranulation (Figure 8D). This
led to high (50–90%) efficiencies of lysis, p, at the beginning of the
assay (s=(szw)), but uncertainty in w obscured any potential
variation in efficiency with peptide dose (Figure 8E). Similarly we
detected no significant differences in the rate of change of
parameters, m indicating that a progressive loss of CTL
functionality affected the killing of all cell populations equally
(Figure 8F). Lastly, we estimated that degranulated (LAMP1a+)
conjugates took between 100 and 200 minutes either to break up
or for the target cell to disintegrate (Figure 8G), again with no
significant T-B differences.
Multiple CTL bound to single targets may shorten the time
taken to kill [4]. We saw evidence for formation of conjugates
comprising more than two cells at approximately 10% of doublet
numbers after one hour, and stable over time (Text S1, section G).
The data were not sufficient to parameterise the dynamics of
theses multiples. However, one could reasonably assume that
triplets form by a second CTL joining a CTL-target doublet,
particularly because CTL were in excess (Text S1, section G). The
estimated pre-lytic doublet loss rate w will then comprise both
breakup into singlets and formation of LAMP1a2 triplets, then
quadruplets, etc., within which targets may or may not have an
increased probability of being killed. Therefore, by neglecting
multiples we may overestimate the true conjugate breakup rate w,
and so our efficiency of killing is a lower bound, with an error of
10% or less. Again, CTL are in excess in these assays and so
estimates of the doublet conjugate formation rate x and the
doublet lysis rate s will be unchanged.
In summary, we found that while the rate of conjugate
formation fell with peptide dose, there were no detectable
differences in the ability of CTL to conjugate with T or B cells;
and while T cells subsequently progressed to lysis more slowly than
B cells, there were no detectable differences in the efficiency of lysis
across cell type or peptide dose. A similar conclusion regarding the
effect of peptide dose on conjugation was reached by Jenkins et al.
[34], who measured the impact of the avidity of TCR-pMHC
interations on lysis using transgenic OT-I CTL specific for the
OVA257–264 peptide. There, the avidity of TCR interactions,
assumed positively correlated with peptide dose, impacted the rate
of formation of conjugates but had no significant effect on the
proportion of conjugates exhibiting clustering of tyrosine kinases at
the contact site, an early indicator of TCR signaling and
progression to lysis. In contrast, lytic efficiency was found to vary
with dose in an in vitro tissue model of killing of HIV-derived
peptide-pulsed targets [26]. Measurements of rates of conjugate
formation and lytic efficiency are somewhat definition-dependent
and correlated, however. We may be overestimating lytic
efficiency and underestimating the rate of conjugate formation
since what we define as a conjugate has remained stable for long
enough to be detected by flow cytometry.
Discussion
Differences in rates of killing of T and B cells by spleen-
resident CTL are likely due to spatial heterogeneity in CTL
motility or differences in target cell trafficking patterns,
and not intrinsic differences in susceptibility to lysis
The in vivo killing assay and the imaging indicated that if killing
of T and B cells was restricted to their respective areas in the
spleen and rates were locally linear in CTL numbers, differences in
local CTL densities were too great to explain the differences in
killing rates of the two populations. This suggested that the effect
of excess CTL in T cell areas may be partly compensated by more
efficient CTL surveillance in B cell areas – either by an increased
rate of encounter with cells of all types, or by B cells being killed
with a higher probability than T cells following conjugation
(Figure 5C). However the rate of formation of conjugates with
CTL, and the probability of progression to lysis, were indistin-
guishable for T and B cells in vitro, and so together these
assumptions and observations prompt the conclusion that the rate
at which CTL survey cells of any type is higher in B cell follicles
than in T cell areas.
While that remains to be tested, the assumption of killing of
each population being entirely restricted to their respective areas
in the white pulp is questionable. Both target cell populations enter
the spleen through the circulation and enter the white pulp via the
marginal zone. At least a proportion of B cells then migrate
through CTL-rich T cell areas en route to B cell follicles [30].
Lymphocytes egressing from the spleen do so by transiting the red
pulp [29], where more than a quarter of splenic F5 CTL resided in
our assay (Figure 5B). Baje´noff et al.[30] observed that between
3 h and 8 h after intravenous transfer of isolated splenocytes, B
Figure 6. Schematic of model of killing of peptide-pulsed
targets by specific CTL in vitro. CTL that have not previously
engaged in lysis (LAMP+, green) initially form conjugates with peptide
pulsed targets (purple) with mass-action kinetics at rate x. These
dissociate at rate w or remain stable till the CTL shows signs of delivery
of lytic granules (LAMP+. The CTL stays bound to its (presumed)
apoptotic targets for mean time 1=g and then dissociates as in the
LAMP+ state (blue).
doi:10.1371/journal.pcbi.1003805.g006
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cells were continuing to accumulate in the white pulp from the
marginal zone that separates the red and white pulp, roughly a
third were resident in B cell follicles, and the remainder were co-
localised with T cells. If similar migration patterns and kinetics
apply in our assays, the difference in the average CTL densities
encountered by the two target cell populations over the assay may
be smaller than that inferred simply from the CTL densities in T
cell areas and B cell follicles alone. It is possible that this effect
alone may account for the differences in T-B killing rates. It is also
not critically dependent on the mass-action assumption, requiring
only that death rates are increasing functions of CTL density over
the conditions found here.
Differences in handling times across target cell type may
only be manifest at low E:T ratios
While we saw no significant differences in the ability of CTL to
conjugate with T or B cells in vitro, or in the probability of
conjugation resulting in lysis, CTL-T cell pairs took more than
twice as long to either break up or progress to lysis. This difference
in handling time will not affect the ability of CTL to control an
Figure 7. Model fits to data from the in vitro killing assay.We applied the model of CTL-target conjugation and killing to data from the in vitro
killing assay, using T and B cell targets pulsed at four different doses of peptide (decreasing, top to bottom). Free target cells are in blue (T cell) or
orange (B cells); green (T cell) and red (B cell) lines are targets in conjugates with F5 CTL that have not degranulated and stain LAMP1a2; black lines
are LAMP1a+ conjugates, which are CTL conjugated to targets following release of lytic granules.
doi:10.1371/journal.pcbi.1003805.g007
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infection when they are in excess, but will become important at
lower E:T ratios when an increasing proportion of CTL will be
sequestered in conjugates at any time, and so may become limiting
[22]. This difference may make growing populations of infected T
cells intrinsically more difficult to control than B cells, in the
absence of spatial or peptide-dose effects. Note here we are
referring to the rate of progression to lysis following encounter, or
single-cell behaviour. This is distinct from the population-level
killing rate K0 which depends only the rate at which CTL can
encounter and identify targets, and not on the handling time,
when CTL are in excess or the mean time to locate the next pulsed
target us much longer than the handling time.
Kinetics of CTL killing are pathogen- and context-
dependent
We predicted a delay of more than an hour before killing of
targets within the spleen was evident. However in an LCMV
infection model, Barber et al. [35] observed substantial loss of
peptide-pulsed cells in the spleen within 15 minutes, relative to
target numbers in uninfected control animals. A similarly rapid
decline of pulsed relative to unpulsed targets was observed in a
polyoma virus infection model [16,36]. It is possible that this faster
loss derives in part from the systemic nature of those infections,
which might lead to greater extra-splenic sequestration or killing of
pulsed targets in rapidly perfused organs such as liver and lung.
Indeed in an LCMV model, Graw et al. [18] saw a roughly four-
fold enrichment for unpulsed transferred cells in the blood by 4
hours, compared to the two-fold enrichment in our assay (Text S1,
section C). However Barber et al. [35] saw that the early loss of
pulsed targets in the spleen was attenuated in mice with CTL
lacking Perforin, a membrane pore-forming protein involved in
the delivery of cytolytic molecules to the target cell. We might
expect filtering of pulsed targets from the blood by 15 minutes to
be similar in these and WT mice, since it is initially TCR- and not
Perforin-dependent. This strongly suggests that lysis was indeed
occurring in the spleen within 15 minutes of cell transfer.
Estimates of the time CTL take to kill targets have varied widely
across systems, from minutes [26,27] to hours [37], and so a
discrepancy of this magnitude is perhaps not surprising. F5 CTL
may simply take longer to kill; we found mean handling times of
30 minutes or longer for T cell targets in vitro, although handling
times with B cell targets were shorter (Figure 8B). The longer delay
before killing is apparent may also derive from the time taken for
CTL and targets to encounter each other. By day 7 the influenza
infection is well controlled and so levels of inflammation are likely
lower than in the LCMV system, which we speculate may result in
reduced CTL motility; and the spatial distribution of specific CTL
that we found in our system may differ from those in LCMV
infection models [38], which might result in differences in the
mean time for ingressing targets to enter CTL-rich areas of the
spleen.
Thresholds of CTL detectability likely lie at very low
pMHC densities and peptide uptake is probably
heterogeneous
Our results recapitulate previous findings that peptide dose
influences susceptibility to lysis by CTL (see, for example,
[16,24,34]). Threshold effects have also been observed. Purbhoo
et al. [24] demonstrated a sigmoid relation between peptide dose
and the extent of lysis at one timepoint in an in vitro cytotoxicity
assay, with a location and steepness that varied with the particular
TCR and peptide but over ranges of peptide doses comparable to
ours. They showed that as few as two pMHC within the interface
between the T cell and its target were sufficient to induce lysis at
least in a proportion of contacts, an effect saturating at between 4-
200 pMHC, consistent with other studies [39,40]. Along similar
Figure 8. Parameter estimates for the model of CTL-target dynamics in vitro. Estimates for T cell targets are in blue; B cells in orange.
Vertical bars show bootstrapped 95% confidence intervals derived from resampling residuals 1000 times. See text for the interpretation of the
parameter values shown in panels A–G.
doi:10.1371/journal.pcbi.1003805.g008
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lines, Henrickson et al. [33] showed in an LCMV model that a
sharp threshold of peptide dose given to dendritic cells (DC) exists
for activation of specific CD8 T cells, corresponding to between 30
and 60 pMHC complexes per DC.
If dissociation of peptide from MHC generates the refractory or
‘invisible’ targets in the in vivo assay, these results suggest that
these targets have reached very low surface densities of specific
pMHC. It is then possible that the greater proportion of refractory
cells among the T cell targets derives in part from their 2–3 fold
lower levels of MHC class I expression (Figure 4). Further, the fact
that we and others [24] observe incomplete killing even in the
populations receiving high doses of peptide suggests heterogeneity
in peptide uptake can be substantial.
Comparing the efficiency of CTL killing of peptide-pulsed
and infected targets
Our work builds on other studies that used the splenic killing
assay and exposes different sources of heterogeneity that need to
be considered when estimating rates of CTL surveillance.
However, the issues that we raise highlight the need for
measurements of CTL efficacy performed with live replicating
pathogens in relevant tissues, for several reasons. First, there
appears to be considerable variation across in vivo cytotoxicity
assays in the parameters defining CTL activity, likely deriving
from differences in microenvironment, TCR specificity, the mode
of CD8 T cell priming and hence effector quality, and target cell
susceptibility. Second, both the in vitro and in vivo analyses
confirmed earlier findings that peptide dose influences the ability
of CTL to detect pulsed targets, but it is not known what peptide
doses yield physiologically relevant levels of cognate pMHC on
target cells. Third, the influenza infection is well-controlled by the
time of the assay 7 days post-challenge; inflammation in the spleen
even while killing of peptide-pulsed targets is occurring is
presumably low, and so CTL motility and any ability to home
to targets may differ between this scenario and one in which an
infection is ongoing. Finally, while we have focused on the lytic
mode of CTL action, they may also control the spread of
intracellular pathogens by non-lytic mechanisms [41,42] that
will presumably not be manifest in assays using peptide-pulsed
targets.
The importance of considering sources of heterogeneity
in host-pathogen dynamics
The parameters defining how CTL survey and kill infected cells
are key elements of models of the within-host dynamics of
intracellular pathogens. Deterministic models assuming homoge-
neous mixing of components of the immune system and infected
cells have been used widely and have provided many mechanistic
insights into the progression and control of viral infections (for a
review, see for example Ref. [43]). While the functional forms of
the terms in these models may be appropriate for describing the
dynamics of an infection, the parameters they contain are usually
compound quantities and may implicitly average over spatial and
cellular heterogeneity. Characterising this heterogeneity is impor-
tant when attempting to make more detailed quantitative
statements regarding host-pathogen interactions. For example, a
substantial number of CTL in our in vivo assay resided in the red
pulp, and would only have been encountered by the proportion of
splenocytes that egress from the white pulp over the course of the
assay. Depending on the time take to transit the red pulp, it may
be that these CTL contribute very little to killing of targets.
Estimates of per-CTL killing rates will then be too low if these
CTL (enumerated following the homogenisation of whole spleens)
are assumed to be co-localised with splenocytes only. With
increasing availability of in-vivo imaging data, quantitative
immunologists will be able to characterise the within-host ecology
of infections in more detail, and specifically the critical sizes of
effector cell populations needed for immunity.
Materials and Methods
Ethics statement
The UK Home Office Project Licence 80/2506 (Development
and function of innate and adaptive immune responses) covers all
animal experiments conducted at the NIMR.
Mice
Ly5.1 C57BL/6J, Ly5.2 C57BL/6J, and F5.Rag1-/- mice were
bred and maintained in a conventional pathogen-free colony at
the National Institute for Medical Research, London, UK. All
lines were of H-2b haplotype. Animal experiments were
performed in accordance with UK Home Office regulations.
Flow cytometry
The following monoclonal antibodies and cell dyes were used:
CD45.2 PE-Cy7, CD45.1 FITC, TCRb APC, B220 PE-
TexasRed (all eBioscience), H-2Db PE (BioLegend), LiveDead
nearIR and CellTrace Violet (both Invitrogen), and H-2Db-
ASNENMDAM dextramer-PE (Immudex). Samples were ac-
quired on CyAn ADP (Dako Cytomation), Canto-II (BD) or
Fortessa X20 (BD) flow cytometers, and analysis was performed
with FlowJo software (Treestar).
Cell culture
Cell culture medium was RPMI supplemented with 10% FCS,
2mM glutamine, 1% penicillin/streptomycin and 50 mM b-
mercaptoethanol (all Sigma).
Preparation of target cells
Splenocytes from naive Ly5.1 or Ly5.2 C57BL/6J mice were
cultured with NP68 peptide (influenza NP366-374, strain A/NT/
60/68, ASNENMDAM, Mimotopes) at 1026 M, 1027 M,
1028 M, 1029 M, or in culture medium alone for unpulsed cells,
for 2 hours at 37uC. These cells were then labelled with CellTrace
Violet (CTV) at either 10 mM, 2.5 mM, 625 nM, 156 nM or
40 nM, respectively. Following peptide pulse and CTV labelling,
target cells were mixed together in equal ratios.
The in vivo cytotoxicity assay
Ly5.1 C57BL/6J mice were injected IV with 2 million lymph
node cells from Ly5.2 F5.Rag1-/- mice and A/NT/60-68
influenza virus, to generate a spleen-resident population of
NP68 specific CTL. Seven days later, 10 million Ly5.2+ target
cells were injected per recipient mouse. At indicated timepoints
from 0.5–24 hours after injection of targets, mice were sacrificed
and spleen and blood were harvested for analysis by flow
cytometry. Care was taken in the timing of both injection and
sacrifice for individual mice, and organs were harvested directly
into ice cold media, to ensure an error of no more than 5 minutes
in the reported timepoints. Target and effector cells were
distinguished from host cells by expression of Ly5.2; CTV
fluorescence was used to identify target cells that had been pulsed
with different doses of peptide, while effector cells were CTV-
unlabelled. Staining for TCRb and B220 was used to identify T
and B cell targets.
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The in vitro conjugation and degranulation assay
To generate effector CTL, lymph node cells from Ly5.2
F5.Rag1-/- mice were activated in vitro for three days in the
presence of NP68 peptide (1028 M). Activated blasts were purified
by Ficoll (GE Healthcare) density-gradient centrifugation and
expanded for a further four days in the presence of 10 nM IL-2
(Peprotech). Ly5.1+ target cells were prepared as described above.
CTL and target cells were added to wells at an E:T ratio of at least
5:1, and briefly centrifuged to initiate cell contact. Cells were co-
cultured at 37uC for the indicated period of time (10 minutes –
2 hours) in the presence of anti-LAMP1a (eBioscience) to detect
degranulation of CTL during the culture period. At the end of the
culture period, cells were immediately fixed with IC fixation buffer
(eBioscience) to preserve E:T conjugates. Samples were then
stained and analysed by flow cytometry, with the addition of a
known number of AccuCount fluorescent particles (Spherotech) to
determine cell counts. Target and effector cells were identified by
expression of Ly5.1 or Ly5.2 respectively, and E:T conjugates by
dual fluorescence for these markers along with forward scatter area
and width characteristics to identify doublets. Staining for TCRb
and B220 was used to identify T and B cell targets, and CTV
fluorescence to identify cells that had been pulsed with different
doses of peptide.
Immunofluorescence
Ly5.1 C57BL/6J mice were injected IV with 2 million lymph
node cells from Ly5.2 F5.Rag1-/- mice and A/NT/60-68
influenza virus, to generate a spleen-resident population of NP68
specific CTL. Seven days later, at the time when in vivo
cytotoxicity assays were performed, mice were sacrificed and
spleens harvested for analysis. Each spleen was cut in two, and the
weight of each segment recorded. One segment was processed for
cell counting and analysis by flow cytometry; the other segment
was immediately frozen in liquid nitrogen. Frozen spleen segments
were then embedded in OCT compound (VWR International). At
least three non-consecutive sections 7 mM thick were cut from
each spleen, and stained with antibodies to Ly5.2, IgD and CD4
(all eBioscience). Separate images for each fluorescence channel
were collected at 20x magnification on a Leica SP5 confocal
microscope, and analysed using ImageJ software (NIH). IgD and
CD4 fluorescence was used to manually identify regions of interest
corresponding to B cell zones, T cell zones and red pulp, and
Ly5.2 fluorescence was subsequently used to enumerate CTL
within each of these regions.
MHC-I turnover assay
Single cell suspensions were prepared from the spleen of
C57BL/6J mice and incubated at 37uC in culture medium for the
indicated periods of time in the presence of 5 mg/mL Brefeldin A
(Sigma) or vehicle control (DMSO, Sigma). Cells were then
washed with PBS and stained for TCRb, B220 and H-2Db for
analysis by flow cytometry.
Modeling of the in vivo cytotoxicity assay
Ordinary differential equation models, described in Results,
were used to simulate the flux of peptide-pulsed and unpulsed
splenocytes from blood into the spleen and the killing of pulsed
targets within the spleen. Parameters were estimated separately for
T and B cell target populations at each peptide dose by fitting
these models to the logit-transformed fractional killing 1{P=fU ,
where P and U are the numbers of pulsed and unpulsed
transferred cell populations recovered from the spleen. The
correction factors f were close to unity and were the ratio of
each peptide-pulsed population to the unpulsed population in the
inoculum. Estimates of f were obtained from the transfer of targets
taken from the prepared splenocyte population into naive animals,
and observing the proportions of the different target cell
populations as they flowed into the spleen. Closed-form solutions
to the models were obtained using Mathematica [44] and fitted to
the data using the nls function in R [45]. Data were logit-
transformed to ensure the normality and heteroscedasticity of the
distribution of residuals. Arcsin square root, complementary log-
log and probit transforms yielded similar parameter estimates and
qualities of fit.
All data used in this manuscript are provided as Supporting
Information (Data S1).
Supporting Information
Data S1 Experimental data. Zipped file containing data
from all experiments, in CSV format.
(ZIP)
Text S1 Supporting Information, sections A–G.
(PDF)
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